Case Series of 9 Patients with Immune Related Adverse Events Associated with Checkpoint Inhibitors

被引：0
|
作者：
Ennis, Daniel [1 ]
Jamal, Shahin [1 ]
To, Fergus [2 ]
机构：
[1] Univ British Columbia, Div Rheumatol, Vancouver, BC, Canada
[2] Univ British Columbia, Vancouver, BC, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2018年 / 45卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2
引用
收藏
页码：971 / 971
页数：1
相关论文
共 50 条
  • [31] Biomarkers for adverse events associated with immune checkpoint inhibitors
    Kourie, Hampig Raphael
    Paesmans, Marianne
    Klastersky, Jean
    BIOMARKERS IN MEDICINE, 2016, 10 (10) : 1029 - 1031
  • [32] Predictors of immune-related adverse events associated with checkpoint inhibitors.
    Alsayed, Alhareth
    Manne, Ashish
    Escobar, Daisy E.
    Sharma, Gaurav
    Prodduturvar, Pranitha
    Alkharabsheh, Omar
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [33] Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sabina Sandigursky
    Adam Mor
    Current Rheumatology Reports, 2018, 20
  • [34] Immune-related adverse events (IrAEs) in patients receiving immune checkpoint inhibitors
    Ferrarini, Alessia
    Benfaremo, Devis
    Rossetti, Giulia
    Morgese, Francesca
    Pomponio, Giovanni
    Berardi, Rossana
    Gabrielli, Armando
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18
  • [35] Incidence and Outcome of Neurologic Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Patients With Melanoma
    Pepys, Jack
    Stoff, Ronen
    Ramon-Gonen, Roni
    Ben-Betzalel, Guy
    Grynberg, Shirly
    Frommer, Ronnie Shapira
    Schachter, Jacob
    Asher, Nethanel
    Taliansky, Alisa
    Nikitin, Vera
    Dori, Amir
    Shelly, Shahar
    NEUROLOGY, 2023, 101 (24) : E2472 - E2482
  • [36] Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sandigursky, Sabina
    Mor, Adam
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (10)
  • [37] Rare Adverse Events Related to Nivolumab, an Immune Checkpoint Inhibitor: A Case Series
    Ganta, Nagapratap
    Alnabwani, Dina
    Keating, Shawn
    Patel, Vraj
    Bommu, Veera Jayasree Latha
    Dawoud, Rand
    Cheriyath, Pramil
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [38] The biomarkers related to immune related adverse events caused by immune checkpoint inhibitors
    Xiao-Hui Jia
    Lu-Ying Geng
    Pan-Pan Jiang
    Hong Xu
    Ke-Jun Nan
    Yu Yao
    Li-Li Jiang
    Hong Sun
    Tian-Jie Qin
    Hui Guo
    Journal of Experimental & Clinical Cancer Research, 39
  • [39] The biomarkers related to immune related adverse events caused by immune checkpoint inhibitors
    Jia, Xiao-Hui
    Geng, Lu-Ying
    Jiang, Pan-Pan
    Xu, Hong
    Nan, Ke-Jun
    Yao, Yu
    Jiang, Li-Li
    Sun, Hong
    Qin, Tian-Jie
    Guo, Hui
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
  • [40] Immune and autoimmune-related adverse events associated with immune checkpoint inhibitors in cancer therapy
    King, G. T.
    Sharma, P.
    Davis, S. L.
    Jimeno, A.
    DRUGS OF TODAY, 2018, 54 (02) : 103 - 122
12345